Unity Biotechnology, Inc. (UNBX)

Unity Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8	7.58	19.8	12.74	32.91	17.81
Short-Term Investments	8.93	15.65	23.4	82.06	55.17	79.89
Cash & Short-Term Investments	16.93	23.23	43.2	94.8	88.08	97.7
Cash Growth	-53.39%	-46.23%	-54.43%	7.63%	-9.85%	-23.37%
Other Receivables	-	0.14	1.58	0.24	-	-
Receivables	-	0.14	1.58	0.24	-	-
Prepaid Expenses	0.71	0.9	1.83	1.51	1.88	3.17
Restricted Cash	-	-	-	-	0.55	-
Total Current Assets	17.65	24.27	46.61	96.54	90.5	100.87
Property, Plant & Equipment	11.73	12.36	18.06	26.87	31.23	36.14
Long-Term Investments	-	-	-	-	1.99	17.87
Other Long-Term Assets	0.97	1.04	1.02	0.95	0.99	1.45
Total Assets	30.35	37.66	65.69	124.35	124.71	156.32

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	1.76	1	1.38	1.79	1.99	2.56
Accrued Expenses	3.38	4.43	3	5.24	6.01	7.36
Current Portion of Long-Term Debt	-	-	-	9.48	4.02	-
Current Portion of Leases	3.93	3.83	3.45	3.1	4.38	4.52
Current Unearned Revenue	-	-	-	-	0.22	-
Other Current Liabilities	-	-	0.01	0.01	0.01	0.02
Total Current Liabilities	9.07	9.26	7.84	19.62	16.62	14.46
Long-Term Debt	-	-	-	10.89	18.41	24.51
Long-Term Leases	18.68	19.71	23.54	26.99	30.09	34.47
Other Long-Term Liabilities	2.81	2.2	5.91	10.76	0.02	-
Total Liabilities	30.55	31.17	37.29	68.27	65.14	73.44

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	517.44	516.82	512.77	500.83	459.64	422.38
Retained Earnings	-517.65	-510.34	-484.35	-444.49	-400.02	-339.3
Comprehensive Income & Other	0	0.02	-0.02	-0.25	-0.04	-0.21
Total Common Equity	-0.21	6.49	28.4	56.08	59.57	82.88
Shareholders' Equity	-0.21	6.49	28.4	56.08	59.57	82.88
Total Liabilities & Equity	30.35	37.66	65.69	124.35	124.71	156.32

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	22.61	23.54	26.99	50.46	56.9	63.5
Net Cash (Debt)	-5.67	-0.31	16.21	44.34	33.17	52.07
Net Cash Growth	-	-	-63.44%	33.67%	-36.30%	-60.10%
Net Cash Per Share	-0.34	-0.02	1.10	4.67	5.94	10.24
Filing Date Shares Outstanding	17.21	16.87	16.79	14.34	6.89	5.47
Total Common Shares Outstanding	17.21	16.87	16.78	14.22	6.3	5.33
Working Capital	8.58	15.01	38.77	76.92	73.89	86.4
Book Value Per Share	-0.01	0.39	1.69	3.95	9.46	15.56
Tangible Book Value	-0.21	6.49	28.4	56.08	59.57	82.88
Tangible Book Value Per Share	-0.01	0.39	1.69	3.95	9.46	15.56
Machinery	-	3.93	4.82	5.34	7.04	7.29
Construction In Progress	-	-	-	-	0.01	-
Leasehold Improvements	-	8.77	9.52	15.24	15.16	15.08

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 29, 2025

Data Sources Report a data error